Vectura and Unilever Ventures announce the spin out of specialty pharmaceutical company Pharmakodex

17-May-2006

Vectura Group plc and Unilever Ventures Ltd announced that they have jointly established a new speciality pharmaceutical company, PharmaKodex Ltd ("PharmaKodex"), to develop a pipeline of pharmaceutical prescription (Rx) and consumer health (OTC) products utilising a range of proprietary oral and transdermal and enabling technologies from Vectura and Unilever.

PharmaKodex is developing a pipeline of improved medicinal products, focusing on re-purposing existing drugs for new indications or combinations, or to provide an improved route of administration. The PharmaKodex development pipeline currently comprises 7 prescription products and 6 OTC products.

PharmaKodex has initiated operations with a strong management team. Chief Executive Officer, Mr Rod Richards, held senior management roles in business and commercial development at Glaxo and SmithKline Beecham, and most recently was CEO at Microscience PLC where he led the business from start up to a successful trade sale in 2005. Prof. John Staniforth, currently Chief Scientific Officer at Vectura, will move to PharmaKodex whilst maintaining a scientific advisory role at Vectura.

Vectura and Unilever Ventures will each retain a significant shareholding in PharmaKodex. Further equity financing will come from specialist venture capital investors.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionising chemistry?

Last viewed contents

The role of goop: Research shows pollution doesn't change the rate of droplet formation

Westlake expands global chlorovinyls manufacturing capacity with acquisition of PVC and VCM plants in Wilhelmshaven, Germany

Westlake expands global chlorovinyls manufacturing capacity with acquisition of PVC and VCM plants in Wilhelmshaven, Germany

Institute for Biology III of the University of Freiburg (Germany) Selects SciQuest to Provide e-Research Services to Scientists

National Starch Launches Program to Reduce Impact of High Milk Prices on Dairy and Other Food Products

Noveon Expands Personal Care Business with Acquisition of Scher Chemicals, Inc.

Borden Chemical Plans Brazil Expansion: Resins and Formaldehyde Manufacturing Complex in Rio Grande do Sul

UK scientists help museum curators to determine Viking trade routes by the metal in their swords

Lyondell Announces Ultrafine TiO2 Expansion at Thann, France Facility

Negative resistivity leads to positive resistance in the presence of a magnetic field

IEC, ISO and ITU, the world's leading developers of International Standards, agree on common patent policy - Use of International Standards to disseminate innovation encouraged by new agreement

Park Electrochemical Corp. announces appointment of Vice President of Advanced Composite Operations

Abbott to Invest S$450 Million (US$280 Million) in Largest Nutritional Plant in Singapore - State-of-the-Art Manufacturing Facility to Support Rapidly Growing Demand for Abbott Nutritional Products in Asia